After Hours
$
318.30
Change
0.00 0.00%
Volume
Volume 44,172
Mar 20, 2023, 5:03 p.m.
Quotes are delayed by 20 min
Today's close
$ 309.09
$ 318.30
Change
+9.21 +2.98%
Day low
Day high
$308.06
$318.71

52 week low
52 week high
$181.00
$320.00

Market cap
$21.49B
Average volume
886,101
P/E ratio
5200.98
Rev. per Employee
$502,038
EPS
0.06
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on PODD
-
DexCom Inc. stock rises Monday, outperforms market
- MarketWatch Automation
-
DexCom Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
DexCom Inc. stock rises Thursday, still underperforms market
- MarketWatch Automation
-
DexCom Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
DexCom Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Bunge to replace Signature Bank in S&P 500, stock rallies 7%
- Claudia Assis
-
DexCom Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
DexCom Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
DexCom Inc. stock outperforms market despite losses on the day
- MarketWatch Automation
-
DexCom Inc. stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
-
DexCom Inc. stock rises Tuesday, outperforms market
- MarketWatch Automation
-
DexCom Inc. stock underperforms Monday when compared to competitors
- MarketWatch Automation
-
DexCom Inc. stock rises Friday, still underperforms market
- MarketWatch Automation
-
DexCom Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
DexCom Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
DexCom Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
DexCom Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
DexCom Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
DexCom Inc. stock rises Thursday, still underperforms market
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
-
Analysts’ Views on Tandem Diabetes Care after Its FDA Approval
- MarketRealist.com
-
Benzinga's Top Upgrades, Downgrades For April 4, 2018
- Benzinga.com
-
Analyst: Insulet On Track For Profitability In 2018
- Benzinga.com
Other News on PODD
-
This Insider Just Sold Shares of Insulet Corp
- GuruFocus.com
-
Tandem upgraded at Wells Fargo as valuation and consensus reset
- Seeking Alpha
-
Insulet stock soars 17% on Q3 beat, raised FY22 revenue outlook
- Seeking Alpha
-
Insulet Corporation (PODD) Q3 2022 Earnings Call Transcript
- Seeking Alpha
-
Insulet: An Overpriced Play In The Medical Space
- Seeking Alpha
-
New Strong Sell Stocks for October 7th
- Zacks.com
-
Bionic Pancreas Shown to Manage Blood-Sugar Levels for Type 1 Diabetics
- The Wall Street Journal Interactive Edition
-
DexCom: Mid-Term Growth Levers In Place Despite Lofty Multiples
- Seeking Alpha
-
DexCom: Great Products, Stock Is Too Expensive
- Seeking Alpha
-
Insulet automated insulin delivery system Omnipod 5 gets CE mark
- Seeking Alpha
- Loading more headlines...
Press Releases on PODD
-
- PR Newswire - PRF
-
Insulet to Present at Upcoming Investor Conferences
- BusinessWire - BZX
-
Insulet Acquires Assets of Automated Glucose Control LLC (AGC)
- BusinessWire - BZX
-
Insulet to Present at Upcoming Investor Conferences
- BusinessWire - BZX
-
Cutting Edge Medical Devices Offer Innovative Options for Diabetics
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com